Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000644275 | SCV000765968 | likely benign | Tuberous sclerosis 2 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV003237970 | SCV002011336 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000644275 | SCV002039305 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002449029 | SCV002612573 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003237970 | SCV005075551 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |